Compounds > centchroman
Page last updated: 2024-09-04

centchroman and ER-Negative PR-Negative HER2-Negative Breast Cancer

centchroman has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Meeran, SM; Mondal, P; Natesh, J; Penta, D1

Other Studies

1 other study(ies) available for centchroman and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Dietary Diindolylmethane Enhances the Therapeutic Effect of Centchroman in Breast Cancer by Inhibiting Neoangiogenesis.
    Nutrition and cancer, 2023, Volume: 75, Issue:2

    Topics: Cell Line, Tumor; Cell Proliferation; Centchroman; Humans; Neovascularization, Pathologic; Triple Negative Breast Neoplasms; Vascular Endothelial Growth Factor A

2023